Journal of Leukemia - Open Access
We are pleased to introduce our Journal: Leukemia, an Open Access Journal publishing original research papers including but not limited to following fields:
Acute lymphoblastic leukemia
Hairy cell leukemia
Chronic lymphocytic leukemia
Large granular lymphocytic leukemia
Acute myelogenous leukemia
T-cell prolymphocytic leukemia
We have a guaranteed 21 days peer review process.
Why with us?
200 Open Access Journals
20000 Eminent editorial team
More than 2 million readers
Publication within 7 days of acceptance
Quality and quick editorial, review processing
Editors, Reviewers and Authors are provided with Scientific Credits
User friendly/feasible website translation of your paper to 50 of the world's leading languages
Enhanced feature: Audio Version of published papers
Digital articles to share and explore
Sharing your published work in social networking like face book, twitter, LinkedIn, RSS feeds etc.
We prefer electronic mode of submission where the articles are peer reviewed & accepted on the basis of Editor’s decision. Authors can track their status through author tracking system.
Submit your manuscript at http://scholarscentral.com/ (or) e-mail to email@example.com
For “Instructions for authors” and to view our eminent editorial team, please visit: http://www.esciencecentral.org/journals/instructionsforauthorsJLU.php
OMICS Group is organizing more than 50 Conferences in 2012-2013, which is an excellent platform to meet fellow researchers, eminent scientists and get updated with latest research happenings around the globe.
For more details please visit: http://omicsonline.org/conferencemain/
With warm regards,
Gracia S Oliver,
OMICS Group Inc.
2360 Corporate Circle
Suite 400, Henderson
NV 89074-7722, USA
Toll Free: +1-800-216-649
“Scholars Central is an evolved platform which focuses on all world class journals, conferences, funding agencies and updates readers with all evolving news and threads the research according the different gateways which actually stands as mirror for all technological advancements around the globe.”
OMICS Publishing Group is the member of/publishing partner of/source content provider to
CrossRef PubMed DOAJ Index Copernicus Scientific Commons
All Published content, except where otherwise noted, is licensed under Creative Commons Attribution License.
This is not a spam message, and has been sent to you because of your eminence in the field. If, however, you do not want to receive any email in future from Journal of Leukemia, then please reply with remove/unsubscribe.